Cytotoxic CD4 T Cells in the Mucosa and in Cancer

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2023 Sep 1

PMID 37654482

Authors

Hrishi Venkatesh

Sean I Tracy

Michael A Farrar

Affiliations

Soon will be listed here.

Abstract

CD4 T cells were initially described as helper cells that promote either the cellular immune response (Th1 cells) or the humoral immune response (Th2 cells). Since then, a plethora of functionally distinct helper and regulatory CD4 T cell subsets have been described. CD4 T cells with cytotoxic function were first described in the setting of viral infections and autoimmunity, and more recently in cancer and gut dysbiosis. Regulatory CD4 T cell subsets such as Tregs and T-regulatory type 1 (Tr1) cells have also been shown to have cytotoxic potential. Indeed, Tr1 cells have been shown to be important for maintenance of stem cell niches in the bone marrow and the gut. This review will provide an overview of cytotoxic CD4 T cell development, and discuss the role of inflammatory and Tr1-like cytotoxic CD4 T cells in maintenance of intestinal stem cells and in anti-cancer immune responses.

Citing Articles

Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging.

Baretti M, Shekhar S, Sahai V, Shu D, Howe K, Gunchick V Hepatol Commun. 2025; 9(3).

PMID: 39969434 PMC: 11841852. DOI: 10.1097/HC9.0000000000000632.

Phase Ib Study of Immunocytokine Simlukafusp Alfa (FAP-IL2v) Combined with Pembrolizumab for Treatment of Advanced and/or Metastatic Melanoma.

Munoz-Couselo E, Soria Rivas A, Sandhu S, Long G, Sanmamed M, Spreafico A Cancer Res Commun. 2025; 5(2):358-368.

PMID: 39895413 PMC: 11848832. DOI: 10.1158/2767-9764.CRC-24-0601.

Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints.

Dai Y, Dong C, Wang Z, Zhou Y, Wang Y, Hao Y Front Immunol. 2025; 15():1482291.

PMID: 39845973 PMC: 11750830. DOI: 10.3389/fimmu.2024.1482291.

Food antigens suppress small intestinal tumorigenesis.

Sasaki T, Ota Y, Takikawa Y, Terrooatea T, Kanaya T, Takahashi M Front Immunol. 2024; 15:1373766.

PMID: 39359724 PMC: 11445177. DOI: 10.3389/fimmu.2024.1373766.

Immune cell infiltration and inflammatory landscape in primary brain tumours.

Luce A, Abate M, Scognamiglio G, Montella M, Iervolino D, Campione S J Transl Med. 2024; 22(1):521.

PMID: 38816839 PMC: 11140972. DOI: 10.1186/s12967-024-05309-1.

References

Plitas G, Rudensky A . Regulatory T Cells: Differentiation and Function. Cancer Immunol Res. 2016; 4(9):721-5. PMC: 5026325. DOI: 10.1158/2326-6066.CIR-16-0193. View

London M, Bilate A, Castro T, Sujino T, Mucida D . Stepwise chromatin and transcriptional acquisition of an intraepithelial lymphocyte program. Nat Immunol. 2021; 22(4):449-459. PMC: 8251700. DOI: 10.1038/s41590-021-00883-8. View

Hou L, Yuki K . CCR6 and CXCR6 Identify the Th17 Cells With Cytotoxicity in Experimental Autoimmune Encephalomyelitis. Front Immunol. 2022; 13:819224. PMC: 8844514. DOI: 10.3389/fimmu.2022.819224. View

Roessner P, Llao Cid L, Lupar E, Roider T, Bordas M, Schifflers C . EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4 T cells in chronic lymphocytic leukemia. Leukemia. 2021; 35(8):2311-2324. PMC: 8324479. DOI: 10.1038/s41375-021-01136-1. View

Verma S, Weiskopf D, Gupta A, McDonald B, Peters B, Sette A . Cytomegalovirus-Specific CD4 T Cells Are Cytolytic and Mediate Vaccine Protection. J Virol. 2015; 90(2):650-8. PMC: 4702662. DOI: 10.1128/JVI.02123-15. View

Montgomery R, Carlone D, Richmond C, Farilla L, Kranendonk M, Henderson D . Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Proc Natl Acad Sci U S A. 2010; 108(1):179-84. PMC: 3017192. DOI: 10.1073/pnas.1013004108. View

Pearce E, Mullen A, Martins G, Krawczyk C, Hutchins A, Zediak V . Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science. 2003; 302(5647):1041-3. DOI: 10.1126/science.1090148. View

Chuang Y, Hung M, Cangelose B, Leonard J . Regulation of the IL-10-driven macrophage phenotype under incoherent stimuli. Innate Immun. 2016; 22(8):647-657. PMC: 5292318. DOI: 10.1177/1753425916668243. View

Raetz M, Hwang S, Wilhelm C, Kirkland D, Benson A, Sturge C . Parasite-induced TH1 cells and intestinal dysbiosis cooperate in IFN-γ-dependent elimination of Paneth cells. Nat Immunol. 2012; 14(2):136-42. PMC: 3552073. DOI: 10.1038/ni.2508. View

10.

Denning T, Norris B, Medina-Contreras O, Manicassamy S, Geem D, Madan R . Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J Immunol. 2011; 187(2):733-47. PMC: 3131424. DOI: 10.4049/jimmunol.1002701. View

11.

Gonzalez-Navajas J, Fan D, Yang S, Yang F, Lozano-Ruiz B, Shen L . The Impact of Tregs on the Anticancer Immunity and the Efficacy of Immune Checkpoint Inhibitor Therapies. Front Immunol. 2021; 12:625783. PMC: 7952426. DOI: 10.3389/fimmu.2021.625783. View

12.

DeStefano Shields C, White J, Chung L, Wenzel A, Hicks J, Tam A . Bacterial-Driven Inflammation and Mutant Expression Combine to Promote Murine Colon Tumorigenesis That Is Sensitive to Immune Checkpoint Therapy. Cancer Discov. 2021; 11(7):1792-1807. PMC: 8295175. DOI: 10.1158/2159-8290.CD-20-0770. View

13.

Takashima S, Martin M, Jansen S, Fu Y, Bos J, Chandra D . T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage. Sci Immunol. 2019; 4(42). PMC: 7239329. DOI: 10.1126/sciimmunol.aay8556. View

14.

Bacchetta R, Bigler M, Touraine J, Parkman R, Tovo P, Abrams J . High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med. 1994; 179(2):493-502. PMC: 2191349. DOI: 10.1084/jem.179.2.493. View

15.

Geginat J, Vasco C, Gruarin P, Bonnal R, Rossetti G, Silvestri Y . Eomesodermin-expressing type 1 regulatory (EOMES Tr1)-like T cells: Basic biology and role in immune-mediated diseases. Eur J Immunol. 2023; 53(5):e2149775. DOI: 10.1002/eji.202149775. View

16.

Nagasaki J, Togashi Y, Sugawara T, Itami M, Yamauchi N, Yuda J . The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma. Blood Adv. 2020; 4(17):4069-4082. PMC: 7479950. DOI: 10.1182/bloodadvances.2020002098. View

17.

Brown D, Lee S, Garcia-Hernandez M, Swain S . Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection. J Virol. 2012; 86(12):6792-803. PMC: 3393557. DOI: 10.1128/JVI.07172-11. View

18.

Melenhorst J, Chen G, Wang M, Porter D, Chen C, Collins M . Decade-long leukaemia remissions with persistence of CD4 CAR T cells. Nature. 2022; 602(7897):503-509. PMC: 9166916. DOI: 10.1038/s41586-021-04390-6. View

19.

Liadi I, Singh H, Romain G, Roysam B, Cooper L, Varadarajan N . Defining potency of CAR T cells: Fast and furious or slow and steady. Oncoimmunology. 2019; 8(10):e1051298. PMC: 6791448. DOI: 10.1080/2162402X.2015.1051298. View

20.

Loebbermann J, Thornton H, Durant L, Sparwasser T, Webster K, Sprent J . Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunol. 2012; 5(2):161-72. PMC: 3282434. DOI: 10.1038/mi.2011.62. View